2026-07-05
The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trialEight weeks of a Lactobacillus/Pediococcus probiotic blend lowered liver enzymes, weight, and cholesterol in MASLD patients, alongside stool microbiome shifts.